Estimated Revenue: $10M to $50M
Funding Status: IPO
Headquarters: Seattle, Washington, United States
Total Funding: 161000000.0
Last Funding Date: 2021-04-07
Investors Number: 15.0
Founded Date: 2017-01-01
Industry: End-to-End Drug Development
Last Funding Type: Series B
Employee Number: 11-50